128 related articles for article (PubMed ID: 6305660)
1. Hormones and risk of breast cancer.
Onnis A; Marchetti M; Graziottin A
Eur J Gynaecol Oncol; 1983; 4(1):13-7. PubMed ID: 6305660
[TBL] [Abstract][Full Text] [Related]
2. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk.
Spicer DV; Ursin G; Parisky YR; Pearce JG; Shoupe D; Pike A; Pike MC
J Natl Cancer Inst; 1994 Mar; 86(6):431-6. PubMed ID: 8120917
[TBL] [Abstract][Full Text] [Related]
3. Exogenous progestins and breast cancer.
Stanford JL; Thomas DB
Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
[TBL] [Abstract][Full Text] [Related]
4. Treatment of breast cancer with medroxyprogesterone acetate.
Muggia FM; Cassieth PA; Ochoa M; Flatow FA; Gellhorn A; Hyman GA
Ann Intern Med; 1968 Feb; 68(2):328-37. PubMed ID: 4306126
[TBL] [Abstract][Full Text] [Related]
5. Pilot trial of a gonadotropin hormone agonist with replacement hormones as a prototype contraceptive to prevent breast cancer.
Spicer DV; Pike MC; Pike A; Rude R; Shoupe D; Richardson J
Contraception; 1993 May; 47(5):427-44. PubMed ID: 8390340
[TBL] [Abstract][Full Text] [Related]
6. Benign breast tumor and estrogenic hormones: a population-based retrospective study.
Nomura A; Comstock GW
Am J Epidemiol; 1976 May; 103(5):439-44. PubMed ID: 179318
[TBL] [Abstract][Full Text] [Related]
7. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
van den Berg HW; Martin J; Lynch M
Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
[TBL] [Abstract][Full Text] [Related]
8. Benefits and risks of menopausal estrogen and/or progestin hormone use.
Ernster VL; Bush TL; Huggins GR; Hulka BS; Kelsey JL; Schottenfeld D
Prev Med; 1988 Mar; 17(2):201-23. PubMed ID: 2843846
[TBL] [Abstract][Full Text] [Related]
9. Oral contraceptives, postmenopausal oestrogen-progestagen use and breast cancer.
Gambrell RD
J Obstet Gynaecol (Lahore); 1984 Apr; 4(Suppl 2):S121-7. PubMed ID: 12339859
[TBL] [Abstract][Full Text] [Related]
10. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
[TBL] [Abstract][Full Text] [Related]
11. Progestins and breast cancer: an epidemiologic review.
Staffa JA; Newschaffer CJ; Jones JK; Miller V
Fertil Steril; 1992 Mar; 57(3):473-91. PubMed ID: 1740192
[TBL] [Abstract][Full Text] [Related]
12. Fibrocystic breast disease: pathophysiology, pathomorphology, clinical picture, and management.
Vorherr H
Am J Obstet Gynecol; 1986 Jan; 154(1):161-79. PubMed ID: 3511705
[TBL] [Abstract][Full Text] [Related]
13. Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.
Gallagher JC; Kable WT; Goldgar D
Am J Med; 1991 Feb; 90(2):171-8. PubMed ID: 1847582
[TBL] [Abstract][Full Text] [Related]
14. Effects of long-term estrogen replacement therapy. II. Neoplasia.
Hammond CB; Jelovsek FR; Lee KL; Creasman WT; Parker RT
Am J Obstet Gynecol; 1979 Mar; 133(5):537-47. PubMed ID: 220875
[TBL] [Abstract][Full Text] [Related]
15. Risks of estrogens and progestogens.
L'Hermite M
Maturitas; 1990 Sep; 12(3):215-46. PubMed ID: 2170823
[TBL] [Abstract][Full Text] [Related]
16. Clinical use of oestrogens and progestogens.
Lauritzen C
Maturitas; 1990 Sep; 12(3):199-214. PubMed ID: 2215269
[TBL] [Abstract][Full Text] [Related]
17. Exogenous hormones in the aetiology of cancer in women.
Vessey MP
J R Soc Med; 1984 Jul; 77(7):542-9. PubMed ID: 6379176
[TBL] [Abstract][Full Text] [Related]
18. Menopausal estrogens and breast cancer.
Hoover R; Gray LA; Cole P; MacMahon B
N Engl J Med; 1976 Aug; 295(8):401-5. PubMed ID: 180409
[TBL] [Abstract][Full Text] [Related]
19. Prescription contraceptives: countering the risks.
Ruggiero RJ
Am Pharm; 1985 Sep; NS25(9):32-7. PubMed ID: 4050670
[TBL] [Abstract][Full Text] [Related]
20. Mammary tumors and serum hormones in the bitch treated with medroxyprogesterone acetate or progesterone for four years.
Frank DW; Kirton KT; Murchison TE; Quinlan WJ; Coleman ME; Gilbertson TJ; Feenstra ES; Kimball FA
Fertil Steril; 1979 Mar; 31(3):340-6. PubMed ID: 437169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
